MEP of the week

Lobby organisation

Johnson & Johnson

Company · Health & pharma · HQ: United States · Transparency Register entry

As of 7 November 2026, Johnson & Johnson appears in 79 declared MEP meetings (50 different MEPs), most often with European People's Party.

79
declared meetings
with current MEPs
50
MEPs met
€900k/yr
declared lobbying spend
self-reported to the register
6.2
lobbyists
full time equivalent

In their own words

“At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life.”

Read the rest of the statementShow less of the statement

“Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 79 declared meetings, by the meeting MEP's political group.

European People's Party3747%
Socialists & Democrats2228%
Renew Europe1114%
European Conservatives & Reformists56%
Patriots for Europe45%

Meetings by year

Declared meetings per calendar year, 2019–2026. Bar length is relative to its busiest year (29 in 2025). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.

2019
3
2020
0
2021
0
2022
4
2023
9
2024
9
2025
29
2026
25

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Tomislav Sokol
5 meetings · EPP
Tiemo Wölken
4 meetings · S&D
Billy Kelleher
3 meetings · Renew

The 15 most recent declared meetings

DateMEPSubject
20 Oct 2026Diego SolierExchange of Views
20 Oct 2026Tiemo WölkenMDR/IVDR Revision and Biotech Act
11 Sep 2026Karin KarlsbroBattery labeling
3 Sep 2026András Tivadar KuljaBiotech
30 Jun 2026Carlo CiccioliBiotech Act
23 Jun 2026Lukas MandlBiotech Act I
9 Jun 2026Kristoffer StormEU Biotech Act
2 Jun 2026Kristian VigeninBiotech Act
1 Jun 2026András GyürkEU Biotech Act
1 Jun 2026Viktória FerencIntroduction, exchange of views on Biotech Act
26 May 2026Tiemo WölkenBiotech Act
20 May 2026Elena Nevado del CampoBiotech Act
11 May 2026Margarita de la Pisa CarriónSANT COMMITTEE ONGOING WORK
29 Apr 2026Nicolás González CasaresPharmaceutical Policy EU-US Trade
28 Apr 2026Ingeborg ter LaakBiotech Act

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.